Real-world use of sunitinib in Japanese patients with pancreatic neuroendocrine tumors: results from a post-marketing surveillance study

por Sato, Kazuo, Toyoshima, Yasuharu, Moriyama, Shiho, Endo, Yutaka, Ito, Tetsuhide, Ohki, Emiko
Publicado 2018

Efficacy and safety of sunitinib in Japanese patients with progressive, advanced/metastatic, well-differentiated, unresectable pancreatic neuroendocrine tumors: final analyses from...

por Ito, Tetsuhide, Tori, Masayuki, Hashigaki, Satoshi, Kimura, Nobuyuki, Sato, Kazuo, Ohki, Emiko, Sawaki, Akira, Okusaka, Takuji
Publicado 2019

Safety, efficacy and prognostic analyses of sunitinib in the post-marketing surveillance study of Japanese patients with gastrointestinal stromal tumor

por Komatsu, Yoshito, Ohki, Emiko, Ueno, Naomi, Yoshida, Ai, Toyoshima, Yasuharu, Ueda, Eiji, Houzawa, Hiroyuki, Togo, Kanae, Nishida, Toshirou
Publicado 2015

Developing Artificial Intelligence Models for Extracting Oncologic Outcomes from Japanese Electronic Health Records

por Araki, Kenji, Matsumoto, Nobuhiro, Togo, Kanae, Yonemoto, Naohiro, Ohki, Emiko, Xu, Linghua, Hasegawa, Yoshiyuki, Satoh, Daisuke, Takemoto, Ryota, Miyazaki, Taiga
Publicado 2022

Feasibility study of two schedules of sunitinib in combination with pemetrexed in patients with advanced solid tumors

por Okamoto, Isamu, Shimizu, Toshio, Miyazaki, Masaki, Tsurutani, Junji, Ichikawa, Yasuko, Terashima, Masaki, Takeda, Masayuki, Fumita, Soichi, Ohki, Emiko, Kimura, Nobuyuki, Hashimoto, Junichi, Nakagawa, Kazuhiko
Publicado 2010

Figitumumab combined with carboplatin and paclitaxel in treatment-naïve Japanese patients with advanced non-small cell lung cancer

por Goto, Yasushi, Sekine, Ikuo, Tanioka, Maki, Shibata, Takashi, Tanai, Chiharu, Asahina, Hajime, Nokihara, Hiroshi, Yamamoto, Noboru, Kunitoh, Hideo, Ohe, Yuichiro, Kikkawa, Hironori, Ohki, Emiko, Tamura, Tomohide
Publicado 2011

Phase I and pharmacokinetic study of dacomitinib (PF-00299804), an oral irreversible, small molecule inhibitor of human epidermal growth factor receptor-1, -2, and -4 tyrosine kina...

por Takahashi, Toshiaki, Boku, Narikazu, Murakami, Haruyasu, Naito, Tateaki, Tsuya, Asuka, Nakamura, Yukiko, Ono, Akira, Machida, Nozomu, Yamazaki, Kentaro, Watanabe, Junichiro, Ruiz-Garcia, Ana, Imai, Keiji, Ohki, Emiko, Yamamoto, Nobuyuki
Publicado 2012

Crizotinib versus Chemotherapy in Asian Patients with ALK-Positive Advanced Non-small Cell Lung Cancer

por Nishio, Makoto, Kim, Dong-Wan, Wu, Yi-Long, Nakagawa, Kazuhiko, Solomon, Benjamin J., Shaw, Alice T., Hashigaki, Satoshi, Ohki, Emiko, Usari, Tiziana, Paolini, Jolanda, Polli, Anna, Wilner, Keith D., Mok, Tony
Publicado 2018

Phase II study of sunitinib in Japanese patients with unresectable or metastatic, well-differentiated pancreatic neuroendocrine tumor

por Ito, Tetsuhide, Okusaka, Takuji, Nishida, Toshirou, Yamao, Kenji, Igarashi, Hisato, Morizane, Chigusa, Kondo, Shunsuke, Mizuno, Nobumasa, Hara, Kazuo, Sawaki, Akira, Hashigaki, Satoshi, Kimura, Nobuyuki, Murakami, Mami, Ohki, Emiko, Chao, Richard C., Imamura, Masayuki
Publicado 2013